ArticleFrontiers in immunology2026
Knockout of PARP2 in T cells leads to spontaneous colitis with distinct segmental characteristics in PARP1-deficient mice.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aim: Suppression of poly(ADP-ribose) polymerase (PARP) activity, either PARP1 or PARP2, was proven to be beneficial in experimental colitis. The absence of PARP2 exclusively in T cells (T-PARP2-KO) was also shown recently to exert similar protection. Nevertheless, lower PARP1 expression in the intestines and reduced PARP activity in mononuclear cells from IBD patients were reported. Thus, we would like to investigate the effect of PARP2 deficiency in T cells superimposed on a PARP1 deletion background in the large intestines. Methods: DKO animals were generated from crossbreeding mice bearing single knockouts. The large intestines were examined by histopathology and various immune-based methods (immunohistochemistry, ELISA, and Western blot) to characterize the intestinal alterations through comparison with control and single knockout animals. Results: The DKO animals developed spontaneous intestinal inflammation in both the proximal and distal large intestines, reflected by both histological features and altered levels of the pro-inflammatory cytokine TNFα. In DKO animals, higher density of T cells and increased oxidative-nitrative stress were observed in the intestinal epithelium. Altered expression and activation of intracellular inflammatory signaling transduction proteins were found exclusively in the proximal segments, while the distal large intestines displayed elongated crypts despite the higher activation of caspase-3. The higher ratio of Ki-67-positive cells imply that the increased renewal of enterocytes is attributable to mucosal hyperplasia. Conclusions: PARPs may have essential roles in maintaining the integrity of large intestines, which are closely associated with lymphatic tissues. The combined genetic modification could potentially induce harmful alterations of the mucosa and the associated lymphatic tissue, leading to the occurrence of spontaneous inflammation with certain distinct segmental features.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.